Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11--Questions and Answers; Draft Guidance for Industry; Availability

1 organizations filed 2 public comments on Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11--Questions and Answers; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1170d ago.

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  2 filings · confidence 97%